WE Fibbe

2.7k citations
36 papers · 1.9k indexed · h-index 24

Impact in

  • Hematology top 1%
    • Hematopoietic Stem Cell Transplantation
    • Acute Myeloid Leukemia Research
  • Immunology top 5%
    • Immune Cell Function and Interaction
    • Immunotherapy and Immune Responses
    • T-cell and B-cell Immunology
    • Immune Response and Inflammation

Papers in

    • Hematopoietic Stem Cell Transplantation 13
    • Acute Myeloid Leukemia Research 5
    • Immune Response and Inflammation 12
    • Immunotherapy and Immune Responses 11
    • Immune Cell Function and Interaction 5

WE Fibbe

36 papers receiving 1.8k citations

Peers

WE Fibbe
Comparison fields: 5 of 93
  • Hematology 823
  • Immunology 759
  • Genetics 302
  • Oncology 498
  • Pathology and Forensic Medicine 319
Replace Joel M. Rappeport with:
Joel M. Rappeport United States
Gunnar Öberg Sweden
Barbara Degar United States
Irena Sniecinski United States
Esteban Abella United States
Nicolás Novitzky South Africa
M. Peetermans Belgium
Pierre Stryckmans Belgium
Edward Kanfer United Kingdom
Henry C. Fung United States
WE Fibbe relative to Joel M. Rappeport United States Joel M. Rappeport's profile →
Citations per field
00.5×3.4×
Joel M. Rappeport · 1×
Citations per year

Countries citing papers authored by WE Fibbe

Since Specialization
Citations

This map shows the geographic impact of WE Fibbe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by WE Fibbe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites WE Fibbe more than expected).

Fields of papers citing papers by WE Fibbe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by WE Fibbe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by WE Fibbe. The network helps show where WE Fibbe may publish in the future.

Co-authorship network

The 25 scholars most cited alongside WE Fibbe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with WE Fibbe Line = papers co-authored together WE Fibbe links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 201011
2 2007122
3 20051
4 200246
5 200147
6 200177
7 2000129
8 2000126
9 199945
10 1997151
11 199232
12 199258
13
In vivo use of Campath-1G to prevent graft-versus-host disease and graft rejection after bone marrow transplantation.
199231
14 199135
15 1989144
16 198812
17 198835
18 198611
19 198518
20 198532

About WE Fibbe

WE Fibbe is a scholar working on Hematology, Immunology, Genetics, Physiology and Pathology and Forensic Medicine, having authored 36 papers that have together received 1.9k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (13 papers), Immune Response and Inflammation (12 papers), Immunotherapy and Immune Responses (11 papers), Acute Myeloid Leukemia Research (5 papers), Immune Cell Function and Interaction (5 papers), Chronic Lymphocytic Leukemia Research (4 papers), Erythrocyte Function and Pathophysiology (3 papers) and Neonatal Respiratory Health Research (3 papers). The work is most often cited by research in Hematology (823 citations), Immunology (759 citations), Genetics (302 citations), Oncology (498 citations) and Pathology and Forensic Medicine (319 citations). WE Fibbe has collaborated with scholars based in Netherlands, Belgium and South Africa. Frequent co-authors include Roel Willemze, JH Falkenburg, Jo Van Damme, BW Altrock, Alfons Billiau, Hanneke C. Kluin‐Nelemans, P Ralph, J Jansen, HM Goselink and N Duinkerken. Their work appears in journals such as Blood, The Journal of Experimental Medicine, Bone Marrow Transplantation, Annals of the Rheumatic Diseases and European Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026